Asklepios BioPharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 27
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AEF3DA677DEEN
Leaflet:

Download PDF Leaflet

Asklepios BioPharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Asklepios Biopharmaceutical, Inc. (AskBio) is a biotechnology company that develops and delivers novel protein and cellular based therapies. It offers products such as biostrophin, AskBio009, BNP-CHF, BNP-TLE, BNP-FVIII, BNP-RP and BNP-OA. AskBio offers products for the treatment of muscular dystrophy, hemophilia B, congestive heart failure, epilepsy, hemophilia A, retinitis pigmentos a and osteoarthritis. The company’s BNP is a gene delivery platform technology. It collaborates with corporate, foundation, and academic organizations. The company serves pharmaceutical and biotechnology companies throughout the country. AskBio is headquartered in Chapel Hill, North Carolina, the US.

Asklepios BioPharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Medical Devices Deals, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deal Details
Partnerships
ALS Therapy Enters Into Co-Development Agreement With Asklepios
Licensing Agreements
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A
Asklepios BioPharma Enters Into Licensing Agreement With Pfizer

AAV2-ASPA-BASED METABOLIC INTERVENTION FOR ALZHEIMER'S DISEASE

PRECLINICAL STUDIES SUPPORTING PHASE IB STUDY OF MINIDYSTROPHIN GENE IN AAV VECTO

SELF-COMPLEMENTARY AAV2 FACTOR IX FOR HEMOPHILIA B

Acquisition
Baxter International To Acquire Chatham Therapeutics From Asklepios BioPharma For US$70 Million
Asklepios BioPharmaceutical, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Key Facts
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Deals By Therapy Area, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Medical Devices Deals, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
ALS Therapy Enters Into Co-Development Agreement With Asklepios
Benitec Biopharma Enters into Licensing Agreement with Asklepios BioPharma
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Duplex Gene Therapy Vector Technology
Asklepios BioPharma Enters Into Licensing Agreement With Genzyme For Intra-Strand Base-Pairing Technology
Asklepios BioPharma Enters Into Licensing Agreement With REGENX Biosciences For Hemophilia A
Asklepios BioPharma Enters Into Licensing Agreement With Pfizer
AAV2-ASPA-BASED METABOLIC INTERVENTION FOR ALZHEIMER'S DISEASE
PRECLINICAL STUDIES SUPPORTING PHASE IB STUDY OF MINIDYSTROPHIN GENE IN AAV VECTO
SELF-COMPLEMENTARY AAV2 FACTOR IX FOR HEMOPHILIA B
Baxter International To Acquire Chatham Therapeutics From Asklepios BioPharma For US$70 Million
Asklepios BioPharmaceutical, Inc., Key Competitors
Asklepios BioPharmaceutical, Inc., Key Employees

LIST OF FIGURES
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Asklepios BioPharmaceutical, Inc., Medical Devices Deals, 2009 to YTD 2015
Skip to top


Ask Your Question

Asklepios BioPharmaceutical, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: